Interested in modeling HPV/cervical cancer?! Thanks to an incredible, collaborative team, we have just released the first of its kind open source model of HPV transmission and cervical disease progression. Go check it out and let us know what you think! https://t.co/IbcS5M5n18
Our latest work under review uses HPVsim to examine the key determinants of an #HPV therapeutic vaccine. Check out preprint here: https://t.co/mK7jdx73IA
Excited to share a novel approach to estimate changes in #malaria burden! We combine spatiotemporal mapping and mechanistic modeling in a computationally efficient way to produce malaria transmission and intervention impact maps: https://t.co/juVPEgnkps
Our work estimating the health impact of current and next generation vaccines in the face of an evolving Covid-19 pandemic using Covasim is finally out @CellReports https://t.co/JX7QUY9Zam
We have a long-standing goal of working towards improving public health through the creation and sharing of modeling tools. Open-source models such as #Covasim have been a valued resource for policymakers, and we are so excited to announce 2 new models: #HPVsim and #FPsim!
Interested in modeling HPV/cervical cancer?! Thanks to an incredible, collaborative team, we have just released the first of its kind open source model of HPV transmission and cervical disease progression. Go check it out and let us know what you think! https://t.co/IbcS5M5n18
The future of Covid vaccines that we need now, a new feature @Nature by @ewencallaway, including nasal, for mucosal immunity, and universal, more durable, variant-proof ones with less side effects
https://t.co/9U5xO2Ve1B
This is what the future of science looks like:
- large collaboration
- computationally based
- open by default
- Cliff Kerr from @IDMOD_ORG presenting covasim at #SciPy2022
“You don’t use the quiet to forget.
You use the quiet periods to do the hard work,”
@JenniferNuzzo brings the truth we need on what the US must do NOW to prepare for the next variant and the next pandemic threat. @benjmueller@nytimes@PPI_Insights https://t.co/W4ixw6xFEJ
High population immunity & the emergence of immune evasive #covid variants reduces impact of current vaccines. Variant-chasing #vaccine strategies fall short, so mitigating future burden requires next gen vaccines & redressing distribution inequities https://t.co/4CsUUohBco
🆕 @CellCellPress
Omicron breakthrough infections induce a weak neutralizing antibody response, ~1/10 that of Delta, 1/3 of a booster shot, "suggesting reduced protection vs infection or a future variant"
https://t.co/ZVmbKkbnrh @cychiu98@TheOttLab@UCSFMedicine@GladstoneInst
Epidemics always trigger a panic-neglect cycle. This has happened for decades, for different pathogens, across administrations, and around the world.
But even against that historical standard, what's happening right now is ABSURD.
https://t.co/XzCN6GJiJF
"The changing impact of vaccines in the COVID-19 pandemic"
A modelling study simulating six hypothetical variants emerging over the next year in a South Africa-like infection- and vaccination-derived immunity setting. 1/5
https://t.co/UItKlhyjE8
@Basucally @HPDSLab @KyuQLee@UW_Pharmacy SO phenomenal congratulations @KyuQLee !! So excited for you and selfishly excited that you will be in Seattle!!